Oncogene Mutation Profiling in Uveal Melanoma

葡萄膜黑色素瘤的癌基因突变分析

• 批准号: 8098940
• 负责人: Ivana Kim
• 金额: $ 16.56万
• 依托单位: MASSACHUSETTS EYE AND EAR INFIRMARY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8098940
• 关键词: Adjuvant Chemotherapy; Behavior; Biological Assay; Biological Markers; Cancer Etiology; Cancer Gene Mutation; Cell Line; Cells; Clinical; DNA; Development; Disease; Drug Delivery Systems; Eye; Gene Mutation; Genome; Genomics; Goals; Histologic; Hot Spot; In Vitro; Intervention; Lead; Malignant Neoplasms; Mass Spectrum Analysis; Melanoma Cell; Molecular; Mutation; Neoplasm Metastasis; Ocular Melanoma; Oncogenes; Oncogenic; Outcome; Paraffin Embedding; Pathogenesis; Patients; Pattern; Pharmaceutical Preparations; Risk Factors; Somatic Mutation; Specimen; Technology; Translations; Tumor Suppressor Genes; Uveal Melanoma; Validation; base; clinically relevant; design; effective therapy; genotyping technology; high throughput technology; improved; malignant phenotype; public health relevance; therapeutic target; tumor

DESCRIPTION (provided by applicant): Despite excellent rates of local control, uveal melanoma, the most common intraocular malignancy, remains lethal in a large proportion of patients due to the lack of treatments for metastatic disease. This application proposes a systematic search for somatic mutations in a large panel of cancer genes in uveal melanoma specimens using a high- throughput, mass spectrometry-based genotyping technology. Using this technology, we will screen for known mutations in over 100 oncogenes and tumor suppressor genes in order to identify specific mutations prevalent in uveal melanoma, establish correlations between particular mutations and clinical outcome, and begin to confirm the functional significance of these mutations in vitro. These studies will provide an important step towards development of rationally-designed, targeted adjuvant chemotherapy necessary for improved survival of patients with the most common intraocular malignancy. PUBLIC HEALTH RELEVANCE: Uveal melanoma is the most common intraocular cancer, and currently, there is no effective treatment for this cancer once it spreads outside the eye. This project will search for over 100 known cancer-causing mutations in this tumor type in hopes of finding targets for new drugs that will improve the survival of patients with this malignancy.

描述(申请人提供)：尽管局部控制率很高，葡萄膜黑色素瘤，最常见的眼内恶性肿瘤，由于缺乏对转移疾病的治疗，在很大一部分患者中仍然是致命的。这项申请提出了一种系统的搜索葡萄膜黑色素瘤标本中一大组癌症基因的体细胞突变的方法，该技术基于高通量、基于质谱仪的基因分型技术。利用这项技术，我们将筛选100多个癌基因和抑癌基因的已知突变，以确定葡萄膜黑色素瘤中普遍存在的特定突变，建立特定突变与临床结果之间的相关性，并开始在体外确认这些突变的功能意义。这些研究将为开发合理设计的、有针对性的辅助化疗提供重要的一步，这是提高最常见的眼内恶性肿瘤患者存活率所必需的。 公共卫生相关性：葡萄膜黑色素瘤是最常见的眼内癌，目前，这种癌症一旦扩散到眼外，就没有有效的治疗方法。该项目将在这种肿瘤类型中寻找100多种已知的致癌突变，希望找到新药的靶点，以提高这种恶性肿瘤患者的存活率。